within Pharmacolibrary.Drugs.ATC.C;

model C08DA01_1
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 0.56,
    adminDuration  = 600,
    adminMass      = 0.01,
    adminCount     = 1,
    Vd             = 0.0029,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Verapamil is a calcium channel blocker used therapeutically to treat hypertension, angina pectoris, and certain arrhythmias such as supraventricular tachycardia. It is approved for use and remains in clinical use today.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters after intravenous bolus administration in healthy adult males.</p><h4>References</h4><ol><li><a href='https://dx.doi.org/10.1007/BF01962343'>10.1007/BF01962343</a> Parameters from: M. Padrini et al., 'Pharmacokinetics of intravenously administered verapamil in humans', European Journal of Clinical Pharmacology (1984), 26:207â€“212.</li></ol></body></html>",
    revisions = "<html><body><ul><li>03/06/2025 model generated from PK parameters and knowledge obtained by LLM gpt-4.1 and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end C08DA01_1;
